Concept Medical Group, a global leader in drug-eluting technologies, has been awarded the prestigious Times Healthcare ...

Orchestra BioMed's AVIM earns FDA breakthrough designation, sparking investor optimism. Click here to read why OBIO stock is ...

Selling, general and administrative expenses for the first quarter of 2025 were $6.3 million, compared with $5.9 million for the first quarter of 2024. The increase was primarily due to an increase in ...

DelveInsight’s, "Neurofibrosarcoma Pipeline Insight 2025,” report provides comprehensive insights about 15+ companies and 15+ ...

Orchestra BioMed Holdings, Inc.’s OBIO share price has surged by 19.92%, which has investors questioning if this is right ...

Patent estate covering atrioventricular interval modulation (“AVIM”) therapy now includes 46 issued U.S. patents and 91 patents outside the U.S. that collectively comprise over 2100 claims related to ...

PBI-Gordon Companies, Inc., an organization that inspires innovations for green spaces, pets, and people, announces the strategic acquisition of TriviumVet®, a leading research and development company ...

Sirolimus may have a higher diffusivity in regions such as fibrofatty and fibrous and lower diffusivity in calcified and necrotic tissue, hence the “soft” model displayed a maximum drug uptake of free ...

The company plans to initiate a U.S. pivotal clinical trial comparing its next-generation Virtue SAB (sirolimus-angioinfusion balloon) to the Boston Scientific Agent paclitaxel-coated balloon.

Researchers have found in new research that low-dose sirolimus is noninferior to high-dose sirolimus in the treatment of Kaposiform Hemangioendothelioma (KHE), suggesting that lower doses may be a ...

Patients were treated with pexidartinib 1000 mg and sirolimus 2 mg orally daily. The primary end point was progression-free survival (PFS). Secondary end points included objective response, safety ...

Currently, systemic administration of sirolimus is recognized as a promising therapeutic approach for complex lymphatic malformations. Nevertheless, the appropriate dosage, optimal blood concentration ...